Drug company sales reps who met with primary care physicians in the U.S. and Canada talked about potential adverse events in 29% of visits, contraindications in 20% of visits and drug interactions in 3% of meetings, according to a study in the Journal of General Internal Medicine. University of British Columbia researchers said unless there is more regulatory oversight, limiting interactions between physicians and sales representatives may be the best way to ensure doctors have the proper information to make prescribing decisions.
Study: Doctors don't always get information on drug risks
SmartBrief Job Listings for Health Care
|Clinical Trials Agreements Specialist (209955)||
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
|Catheter Engineer Manager||
ASAHI INTECC, Orange County CA R&D Center
|Santa Ana, CA|
|Neurovascular Intervention Product Sales Rep, North East||
|Multiple Locations, SL_Multiple Locations|
|Senior Manager, Compliance||
|Director, Office of Device Evaluation||
FDA, Center for Devices and Radiological Health
|Silver Spring, MD|